National Nutrition and Food Technology Research Institute
Tehran, Tehran Province, 19395-4741, Iran
NCT Number: NCT00916188
The primary objective of this study is to evaluate the efficacy of different doses of black tea (150, 300, 450, 600 ml) in the test group compared to 150 ml in the control group, in improving oxidative stress, lipid profiles and insulin sensitivity.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Tehran, Tehran Province, 19395-4741, Iran
A total of 45 patients of known T2DM (16 males and 29 females) were introduced into the controlled clinical trial and randomly assigned to either test (57.0 ± 7.9 yrs, n=23) or control (55.4 •± 8.3 yrs, n=22) group. Patients in control group were instructed to have only one cup (150 ml) of black tea/day, as a 2.5 g tea bag that had to be prepared in a standard way for one week (washout period). Patients in the test group were instructed to have 300, 450, and 600 ml (2, 3, and 4 cups, respectively) in weeks 2, 3 and 4 respectively. We assessed the change in serum glutathion, superoxidismutase, total antioxidant capacity, FBS, CRP, HbA1C, lipid profiles and fibrinogen during the end of each week.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Amount/dose depends on Arm assignment.
Other names: BTE
Time frame: 4 Weeks
National Nutrition and Food Technology Institute
Other
Effects of Black Tea Consumption on Oxidative Stress, Serum Lipid Profile and Insulin Sensitivity in Patients With Type 2 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06362265
Diabetes Mellitus, Diabetes Mellitus, Type 2
Los Angeles, California, United States
View Trial DetailsNCT02227849
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chūbu, Japan
View Trial DetailsNCT02622113
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chugoku, Japan
View Trial DetailsNCT02220920
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chugoku, Japan
View Trial Details